Is rectal indomethacin effective in preventing of post-endoscopic retrograde cholangiopancreatography pancreatitis?

doi:10.3748/wjg.v20.i29.10151

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 29

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6638)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-4) series.

Item

Count

PDF

570

WORD

283

HTML

3557

Tables (1-4)

178

Sum=4588

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

991

Download

1059

Sum=2050

Aug 7, 2014 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (50)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Randomized Controlled Trial

World J Gastroenterol. Aug 7, 2014; 20(29): 10151-10157
Published online Aug 7, 2014. doi: 10.3748/wjg.v20.i29.10151

Table 2 Distribution of specific risk factors in the investigated population (n = 665) n (%)

Risk factors	Indomethacingroup (n = 347)	Control group(n = 318)	P value
Age < 50 yr (n = 104)	57/347 (16.4)	47/318 (14.8)	0.559
Female gender (n = 426)	214/347 (61.7)	212/318 (66.7)	0.180
BMI > 25 (n = 362)	191/347 (55.0)	171/318 (53.8)	0.743
Duration of ERCP > 20 min (n = 211)	111/347 (32.0)	100/318 (31.4)	0.880
Non-dilated bile duct (n = 299)	158/347 (45.5)	141/318 (44.3)	0.757
Pancreatic duct opacification (n = 463)	246/347 (70.1)	217/318 (68.2)	0.534
EST biliary (n = 443)	224/347 (64.6)	219/318 (68.9)	0.195
EST pancreatic/double (n = 48)	20/347 (5.8)	28/318 (8.8)	0.130
Difficult cannulation (n = 116)	64/347 (18.4)	52/318 (16.4)	0.111
Gallstone extraction (n = 165)	82/347 (23.6)	83/318 (26.1)	0.461
Bile duct dilatation (n = 22)	11/347 (3.2)	11/318 (3.5)	0.835
Biliary plastic stent placement (n = 75)	35/347 (10.1)	40/318 (12.6)	0.640
Total (n = 2734)	1413/4164 (33.9)	1321/3816 (34.6)	0.520

BMI: Body mass index; EST: Endoscopic sphincterotomy; ERCP: Endoscopic retrograde cholangiopancreatography.

Citation: Döbrönte Z, Szepes Z, Izbéki F, Gervain J, Lakatos L, Pécsi G, Ihász M, Lakner L, Toldy E, Czakó L. Is rectal indomethacin effective in preventing of post-endoscopic retrograde cholangiopancreatography pancreatitis? World J Gastroenterol 2014; 20(29): 10151-10157
URL: https://www.wjgnet.com/1007-9327/full/v20/i29/10151.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i29.10151